The "EMIT" enzyme immunoassay system (Syva) that involves use of glucose-6-phosphate dehydrogenase (EC 1.1.1.49) as the enzyme label has been adapted to a fully merchanized kinetic enzyme analyzer for analysis of phenobarbital, phenytoin, and primidone. This procedure, compared with the gas-chromatographic procedure of The "enzyme multiplied immunoassay technique" (EMIT) developed by the Syva Corp., Palo Alto, Calif. 94304, provides, at least theoretically, a rapid and fairly specific means of quantifying anti-epileptic drugs in a small volume of serum. Here, we discuss use of the EMIT system with a fully mechanized enzyme analyzer, the KA-150 (Perkin-Elmer Corp., Norwalk, Conn. 06856). The procedures evaluated were those for phenobarbital, phenytoin, and primidone.
Materials and Methods

Instrumentation, Reagents, and Standards
The present method and the Syva-Gilford procedure described in the EMIT product insert were both compared with a gas-liquid chromatographic method (1) .
EMIT assays were performed on a with an auxiliary control panel. The design and operating principles of this instrument are discussed elsewhere (2 from Leuconostoc mesenteroides conjugated with the drug to be measured. We standardized the assay procedure by use of five serum calibrators provided by Syva, each of which contained five different anti-epileptic drugs, and a control serum that contained no drugs. The concentration of the drugs in the serum calibrators encompassed the therapeutic ranges of concentration of the different drugs in serum.
Development
of the Procedure
The buffer supplied with the kit was diluted to 50 ml. For phenytoin and phenobarbital, reagent A was reconstituted in 25 ml of distilled water and reagent B in 25 ml of the buffer solution. For primidone, reagent A was reconstituted in 12.6 ml of distilled water and reagent B in 12. Upon looking at the medical questionnaires completed by these particular donors it appeared to us that there might be a correlation between those whose serum gave very high blanks and those who had given a positive answer either to having had a recent pregnancy or to having recently taken oral contraceptives.
However, when we compared direct and prediluted assay of sera from two groups of women, one group on oral contraceptives and one group not, we found no significant However, this specimen was the only one that when assayed both ways, produced a significantly different result for one of the three drugs.
As linearity on semilog paper was the same with both analytical approaches and matrix effects were no greater with the undiluted specimens, we elected to perform the assay routinely without predilution of specimens for phenytoin and primidone assays. The phenobarbital assay is apparently much more subject to interferences and should only be performed on prediluted specimens. With the KA-150 run as described, the print-out lists enzyme activity in international (IUB) units per liter. We have described elsewhere (3) a treatment of the data that involves a weighted iterative nonlinear regression for fitting the data to a four-parameter logistic curve (4). The drug concentration corresponding to a given measured enzyme activity can then be interpolated from this curve.
Results
Intermethod comparison.
We analyzed 20 to 30 specimens with concentrations of the three drugs ranging from zero to the nearly toxic. We then compared results obtained by our 
Discussion
Elsewhere (3) it is shown that drug screening by use of EMIT-lysozyme reagents can be automated on a centrifugal analyzer. We have shown that the EMIT-glucose-6-phosphate dehydrogenase system can be adapted to a fully mechanized kinetic enzyme analyzer. The precision achieved in the raw data is typically a 1% or better coefficient of variation. However, the slope of the log dose-response curve is low. Thus, a 1% variation in the observed enzyme activity results in a 10 to 15% CV for the interpolated concentration of the antiepileptic drugs. The KA-150 data correlated well with those by gas-liquid chromatography, which has been the accepted procedure for measuring anticonvulsants in serum. The precision obtained by experienced workers with gas chromatography is better than that obtained with the immunoassay. However, with the EMIT system, total analysis time is much less and the sample volume required is at least 10-fold less. In addition, gas-liquid chromatographic assays require that the anticonvulsants first be extracted from serum. The extraction of anticonvulsants, especially of primidone, is often not quantitative.
It has been suggested that EMIT could replace gas-liquid chromatography as the reference procedure for anticonvulsants. We do not agree. The poorer precision relative to gasliquid chromatography for all three drugs and the susceptibility of the phenobarbital assay to interferences would seem to preclude its use as a reference method. 
